ArticleOpen forum infectious diseases2022

Effectiveness of a Third Dose of COVID-19 mRNA Vaccine During the Omicron BA.1- and BA.2-Predominant Periods in Japan: The VENUS Study.

Wataru Mimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.